Search results
Dow Jones Cuts Gains After Hot Inflation Data; Nvidia Rallies On Strong TSMC Sales
Investor's Business Daily· 3 days agoShares gained 1.4% on the stock market today. Meanwhile, drug giant Merck is building a flat base...
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For...
Benzinga· 5 days agoEnveric Biosciences ENVB, a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding...
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
North Denver News· 6 days agoWhen doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was ...
Prediction: 3 Sensational Stocks That'll Be Worth Far More Than Tesla 2 Years From Now
Motley Fool via Yahoo Finance· 3 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
Zacks via Yahoo Finance· 5 days ago-Cellular currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the drug/biotech...
5 Stocks Driving Dow's Market-Beating Performance
Zacks via Yahoo Finance· 3 days agoFurther, the index appears unaffected compared with the other two major indices, which cooled down somewhat in the recent sessions following the latest...
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
InvestorPlace· 4 days agoWhispers and rumors of widespread cannabis legalization are growing louder. Although the last major...
New York needs comprehensive federal reform for the 340B drug pricing program
Gannett via AOL· 7 days agoAn important program for many minority and vulnerable communities is the 340B Drug Pricing Program. Federal policymakers created the 340B Program in 1992 to lower the cost ...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will discuss the 10 stocks whose price targets were recently raised by analysts....
Why Iovance Stock Is Down 18% Today
Motley Fool via Yahoo Finance· 3 days agoBut, it's ultimately a buying opportunity for interested newcomers. See, Amtagvi isn't just a promising drug. It's the first tumor-infiltrating...
